The New Frontier: Why Australian Healthcare Needs a Different Kind of Marketing Agency
- rytashasekhon
- Apr 21
- 5 min read
The New Frontier
There is a new type of founder we keep meeting. She runs a peptide clinic in Melbourne. Or he prescribes medicinal cannabis out of a Gold Coast telehealth practice. Or they've just opened one of the country's first psychedelic-assisted therapy clinics – eighteen months after the TGA down-scheduled psilocybin and MDMA in 2023. These founders are clinically rigorous and obviously ambitious. And they all tell us the same thing during the first strategy call: "Every healthcare marketing agency in Australia I've spoken to has either said no, or promised us the world, regulations be damned."
So why does this keep on happening? Well, at SEKHN, we believe the traditional category of a healthcare marketing agency in Australia is quietly splitting into two.
The Old Category
Consider this: you're a peptide clinic owner and you type in "healthcare marketing agency in Australia" on Google. The results will show you roughly a dozen serious firms that are, for the most part, excellent. Their work is both compliant and careful, and they thrive with clients in general practices, dental clinics, day surgeries, allied health, etc. The language on their website is interchangeable: AHPRA-compliant, TGA-aware, patient-centred, evidence-based (not knocking down these terms – we use them too!), and their case studies feature the same logos. Not to mention the stock photos: sterile, cool-toned pictures of smiling clinicians in pale blue scrubs that look less like willing participants and more like hostages.
This is not a criticism.
It is a description of a mature category serving an equally mature market. The truth is, the Australian general practice has existed in roughly its current form for decades and the marketing discipline around it has, reasonably, calcified into a known set of moves. But calcified categories struggle when a new one emerges underneath them
The New Category
A bird-eye view of the Australian healthcare industry shows a new trend emerging. Somewhere between 2016 when medicinal cannabis was federally legalised and now, a distinct new vertical has formed in the industry. We haven't yet agreed on a name but there's a bunch of terms regularly thrown around: "wellness medicine", "longevity medicine", "frontier medicine". But none of them quite fit. Here's what it actually is: the emerging, often non-conventional, slightly-ahead-of-the-curve corner of Australian medicine that includes medicinal cannabis, prescribed peptides, hormone optimisation, IV therapy, regenerative and stem cell clinics, ketamine clinics, functional medicine, longevity practices, and – since July 2023 – regulated psychedelic-assisted therapy programs.
It sounds 'niche'. But it's not. The TGA has issued over a million medicinal cannabis approvals. Peptide prescribing has moved from obscure to mainstream within the last three years. And Australia is quietly becoming one of the most interesting healthcare markets in the world. This is a country where Schedule 8 reform, a well-structured Special Access Scheme, and a sophisticated private clinical ecosystem have combined to make us early adopters of treatments that most other jurisdictions are still twiddling their thumbs on.
Here's the real catch. The people building this space are not like the people building general practices. They are usually former specialists or GPs who've pivoted. They are often clinician-founders rather than corporate-owned groups. They are operating with real clinical governance and real commercial pressure. And they are navigating a regulatory landscape that os, to put it mildly, not beginner territory:
AHPRA therapeutic claims rules
TGA Schedule 4 and 8 advertising restrictions
DHA guidelines
State-level pharmacy law
Platform-level ad policy at Meta and Google
Very few healthcare marketing agencies in Australia are built for this.
What the Old Model Gets Wrong
At SEKHN, we believe in healthy competition so we don't want to throw our competitors under the bus. Let's be clear, the old-category agencies aren't wrong about compliance. They're simply wrong about what compliance is.
Let's take the example of a GP clinic marketing its bulk-billing service. Here, compliance is sort of like a hygiene layer: don't make therapeutic claims, don't use patient testimonials that fall under Sec 133, stay away from comparative language, etc (it's really an endless list). Agencies apply the checklist and they move on.
However, for, let's say, a medicinal cannabis clinic, compliance is the creative brief. You cannot advertise Schedule 8 substances to consumers. You cannot use terms such as "plant-medicine". You cannot imply that this treatment will prevent or heal any symptoms. Heck, you can't even use a plant emoji! The entire brand and marketing strategy has to be built inside this constraint. That means the creative, the copy, the landing page, the channel mix, the funnel architecture, the retargeting logic, the patient portal – every layer is downstream of the regulation.
The old model treats compliance as something the client worries about and the agency works around. The new model treats compliance as the starting point of the design process. It's the difference between a lawyer who tells you what you can't do and an architect who builds the whole house inside the setback lines.
What We're Actually Doing at SEKHN
SEKHN was never built to be another healthcare marketing agency in Australia. Instead, we set out to build a house that documents and serves the new frontier. Here's what that actually means. One, we don't limit ourselves to just learning from the local landscape. We learn and adapt just as much from international reforms as we do from Australian ones. Two, SEKHN is a studio, but it's also – increasingly – a desk. We research and write about what's happening at the frontier: the people quietly changing the industry, the strange TGA rulings that reshape ad policy overnight, the international developments that will arrive in Australia in twelve months. We know this world deeply because we live in it.
Third, we deliberately keep our client list narrow. While we work with all kinds of healthcare businesses, our speciality lies in frontier services such as peptide clinics, medicinal cannabis brands (both prescriber-platforms and vertically integrated groups), regenerative medicine practices, longevity clinics, and a small number of legacy healthcare groups expanding into frontier services. Any engagement where the clinical governance feels thin is one we do not take on.
The Question We'd Ask Before Hiring Any Agency
If you're a founder in this space trying to choose a healthcare marketing agency in Australia, the filter isn't "do they understand AHPRA and TGA." Every agency says they do. The filter is this: Can they name, without Googling, the three most recent changes to the TGA Advertising Code that affect how I can market what I actually do?
If the answer is yes, you are probably talking to a frontier agency. If the answer is a polite pivot back to SEO packages, you are talking to the old category and you will end up educating them on your own regulatory environment, at your own cost, while they learn.
A Closing Note
The old category of healthcare marketing in Australia isn't going away. Nor should it.
GPs and dental groups and hospitals deserve excellent, compliant, careful marketing partners, and the firms serving them are genuinely good at what they do.
But the new category needs its own institutions. Its own aesthetic. Its own publications. Its own agencies. And right now, most of those are still being built.
SEKHN is what we're building. If you're operating on the frontier – or thinking about entering it – we'd like to hear from you.
SEKHN is a marketing agency in Australia disrupting the healthcare space. Our services include marketing strategy, patient-acquisition funnel optimisation, paid advertising, SEO, social media management, email marketing, brand identity, and AHPRA/TGA-compliant ad and content creative. Every engagement starts with a complimentary website and compliance audit.



Comments